Corbus Pharmaceuticals Holdings, Inc.
Cash Flow History
| Period | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| Mar 2014 | $-140.0K | $-140.0K | — | $5.4K |
| Jun 2014 | $-321.7K | $-321.7K | — | $21.0K |
| Sep 2014 | $-578.3K | $-578.3K | — | $45.5K |
| Dec 2014 | $-1.3M | $-1.3M | — | $121.2K |
| Mar 2015 | $-1.3M | $-1.3M | $1.7K | $302.0K |
| Jun 2015 | $19.5K | $5.0K | $14.5K | $300.9K |
| Sep 2015 | $-2.5M | $-2.5M | $4.8K | $240.7K |
| Dec 2015 | $-881.0K | $-974.0K | $93.0K | $309.8K |
| Mar 2016 | $-2.5M | $-2.6M | $65.3K | $311.2K |
| Jun 2016 | $-2.5M | $-2.6M | $121.8K | $383.0K |
| Sep 2016 | $-3.1M | $-3.1M | $69.9K | $828.1K |
| Dec 2016 | $-5.5M | $-5.6M | $96.0K | $1.6M |
| Mar 2017 | $-6.6M | $-6.7M | $40.1K | $1.6M |
| Jun 2017 | $-5.7M | $-5.8M | $41.7K | $1.3M |
| Sep 2017 | $-6.3M | $-6.4M | $45.4K | $1.4M |
| Dec 2017 | $-9.1M | $-9.7M | $580.2K | $1.5M |
| Mar 2018 | $-1.6M | $-2.9M | $1.3M | $1.9M |
| Jun 2018 | $-5.6M | $-6.2M | $675.2K | $1.8M |
| Sep 2018 | $-8.8M | $-9.0M | $105.8K | $2.0M |
| Dec 2018 | $-14.1M | $-14.3M | $249.8K | $1.9M |
| Mar 2019 | $10.3M | $10.2M | $73.6K | $3.1M |
| Jun 2019 | $-16.4M | $-16.6M | $183.3K | $2.8M |
| Sep 2019 | $-17.1M | $-18.3M | $1.2M | $3.0M |
| Dec 2019 | $-22.6M | $-23.9M | $1.3M | $3.1M |
| Mar 2020 | $-27.6M | $-28.1M | $463.6K | $3.1M |
| Jun 2020 | $-26.6M | $-26.6M | $16.2K | $3.3M |
| Sep 2020 | $-27.3M | $-27.3M | $56.8K | $3.6M |
| Dec 2020 | $-18.2M | $-18.2M | $-52.1K | $2.3M |
| Mar 2021 | $-21.8M | $-21.8M | — | $2.6M |
| Jun 2021 | $-17.5M | $-17.5M | — | $2.5M |
| Sep 2021 | $857.0K | $857.0K | — | $2.6M |
| Dec 2021 | $-9.7M | $-9.7M | — | $1.8M |
| Mar 2022 | $-10.6M | $-10.6M | $13.4K | $1.6M |
| Jun 2022 | $-12.2M | $-12.2M | $0 | $1.5M |
| Sep 2022 | $-7.2M | $-7.2M | $0 | $1.3M |
| Dec 2022 | $-7.5M | $-7.5M | $0 | $1.3M |
| Mar 2023 | $-15.1M | $-15.1M | $0 | $1.0M |
| Jun 2023 | $-7.8M | $-7.8M | $0 | $823.6K |
| Sep 2023 | $-7.2M | $-7.2M | $0 | $821.0K |
| Dec 2023 | $-6.0M | $-6.0M | $0 | $799.0K |
| Mar 2024 | $-8.0M | $-8.0M | — | $982.0K |
| Jun 2024 | $-8.9M | $-8.9M | — | $1.3M |
| Sep 2024 | $-13.9M | $-13.9M | — | $2.2M |
| Dec 2024 | $-10.9M | $-10.9M | — | $1.6M |
| Mar 2025 | $-16.4M | $-16.4M | $0 | $1.7M |
| Jun 2025 | $-16.6M | $-16.6M | $0 | $1.6M |
| Sep 2025 | $-15.6M | $-15.6M | — | $1.6M |
| Dec 2025 | $-15.9M | $-15.9M | — | $1.4M |
| Mar 2026 | $-25.6M | $-25.6M | $6.0K | $1.9M |
| Jun 2026 | $-29.6M | $-29.6M | $6.0K | $1.8M |